Postdoctoral Research Associate at The Centre for Translational Pharmacology, University of Glasgow. Aisling works on a group of receptors called muscarinic receptors which are the target of one of the most commonly used drugs in the treatment of Alzheimer’s disease. Specifically, she studies the M1 muscarinic receptor because this subtype is highly expressed in the brain and has been shown to be involved in cognition. She is investigating the function of the M1 receptor in greater detail so we can design better drugs for Alzheimer’s disease with fewer side effects. Aisling is from Belfast but has lived in Glasgow since 2015 when she started a PhD programme. She lives with her husband, toddler, and her cat Frasier.